InterCure to Participate in the Cowen 3rd Annual European Cannabis Conference

May 15, 2023

Mr. Rabinovitch is one of the global cannabis senior executives to participate

NEW YORK, TORONTO, and HERZLIYA, Israel, May 15, 2023 (GLOBE NEWSWIRE) -- InterCure Ltd. (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) (dba Canndoc)("InterCure") today announced that Alexander Rabinovitch, CEO of InterCure, will participate in the Cowen 3rd Annual European Cannabis Conference, taking place May 16th, 2023 in Berlin, Germany.

Mr. Rabinovitch will take part in the European Frontier Markets & Israel panel on May 16th, 2023 at 10:35 AM CEST, and will be available for 1 on 1 sessions by appointment only.

About InterCure (dba Canndoc)

InterCure (dba Canndoc) (NASDAQ: INCR) (TSX: INCR.U) (TASE: INCR) is the leading, profitable, and fastest growing cannabis company outside of North America. Canndoc, a wholly owned subsidiary of InterCure, is Israel’s largest licensed cannabis producer and one of the first to offer Good Manufacturing Practices (GMP) certified and pharmaceutical-grade medical cannabis products. InterCure leverages its market leading distribution network, best in class international partnerships and a high-margin vertically integrated "seed-to-sale" model to lead the fastest growing cannabis global market outside of North America.

For more information, visit:


InterCure Ltd.
Amos Cohen, Chief Financial Officer